Sign in

You're signed outSign in or to get full access.

Michael DePasquale

Michael DePasquale

Chief Executive Officer at BIO KEY INTERNATIONALBIO KEY INTERNATIONAL
CEO
Executive
Board

About Michael DePasquale

Michael W. DePasquale, age 70, is Chairman and Chief Executive Officer of BIO-key International, Inc. (BKYI); he has served as CEO and Director since January 3, 2003 and as Chairman since January 29, 2014. He previously served as Co-CEO from July 2005 to August 2006, holds a B.S. from the New Jersey Institute of Technology, and brings prior executive roles at McGraw-Hill and Digital Equipment Corporation; he also serves as Vice Chairman of the International Biometrics and Identification Industry Association . In 2024, BKYI generated $6.93M in revenue and a net loss of $(4.30)M, improving from 2023’s $7.75M and $(8.52)M, respectively; over 2022–2024, the “value of $100” TSR metric declined from 26.43 (2022) to 7.53 (2023) to 4.29 (2024) .

Past Roles

OrganizationRoleYearsStrategic impact
BIO-key International, Inc.Chief Executive Officer and Director2003–presentLong-tenured leadership in biometrics/software; board chair since 2014 .
BIO-key International, Inc.Chairman of the Board2014–presentCombined Chair/CEO; fosters management–board communication per board rationale .
BIO-key International, Inc.Co-Chief Executive Officer2005–2006Shared executive leadership during transition period .

External Roles

OrganizationRoleYearsStrategic impact
International Biometrics and Identification Industry AssociationVice Chairman, Board of DirectorsNot disclosedIndustry leadership and domain expertise in biometrics .
McGraw-HillExecutive management positionsNot disclosedPrior operating experience in software/professional services .
Digital Equipment CorporationExecutive management positionsNot disclosedPrior operating experience in technology sector .

Fixed Compensation

Metric202220232024
Base Salary ($)295,833 271,250 285,000
All Other Compensation ($)997 1,027 491
Total Compensation ($)372,080 291,527 309,491

Notes:

  • Employment agreement (auto-renewing annually) states base salary has been $275,000 since 2018, subject to compensation committee adjustments (actual paid each year shown above) .

Performance Compensation

  • Annual cash bonus framework: Historically tied to revenue milestones; none of the revenue milestones were achieved in 2022 or 2023, and Summary Compensation Table shows no bonus paid to the CEO in 2022–2024 .
YearPerformance metricWeightingTargetActualPayout ($)Vesting/Timing
2022Revenue milestonesNot disclosedNot disclosedNot achieved 0 Annual cash cycle
2023Revenue milestonesNot disclosedNot disclosedNot achieved 0 Annual cash cycle
2024Revenue/strategic metricsNot disclosedNot disclosedNot disclosed0 (no bonus in SCT) Annual cash cycle

Equity awards (RSUs) – grants and vesting:

  • Awards under 2023 Plan: Michael W. DePasquale granted 24,000 RSUs; additional 1,945 RSUs outstanding with separate vesting .
  • Plan-level change-in-control treatment: 2015 Plan provides single-trigger full acceleration; 2023 Plan permits committee to accelerate on a change in control .
RSU trancheSharesVesting schedule
2023 Plan grant24,000 Vests in three equal annual installments commencing July 31, 2025 .
Prior RSUs1,945 Vests in two equal annual installments commencing August 29, 2025 .

Stock options (legacy):

Option grantExercisable (#)Exercise price ($)ExpirationIn/Out of the money vs $1.71 (12/31/24)
Legacy option 1232 282.24 03/23/2025 Deep out-of-the-money at $1.71 reference price .
Legacy option 2232 169.92 03/21/2026 Deep out-of-the-money at $1.71 reference price .

Pay-versus-performance context:

Measure202220232024
Compensation Actually Paid to PEO ($)254,494 261,326 277,097
Value of $100 (TSR proxy) ($)26.43 7.53 4.29
Net Loss ($)11,909,903 8,521,837 4,300,692

Equity Ownership & Alignment

ItemDetail
Total beneficial ownership62,918 shares (includes components below) .
Components232 options; 9,167 warrants; 28,120 restricted stock, of which 17,297 unvested .
Shares outstanding reference6,848,775 shares outstanding as of June 20, 2025 (for overall cap-table context) .
Company equity overhangCurrent dilution 3.6%; potential dilution under amended plan 15.0% (company-wide) .
Hedging/pledgingHedging prohibited; no margin accounts; pledging prohibited while in possession of MNPI (partial restriction) .
Ownership guidelinesNo specific executive ownership multiple disclosed; plan permits imposing ownership-related restrictions/guidelines .

Employment Terms

TermKey provision
Employment agreementEffective March 25, 2010; auto-renews annually unless terminated/modified .
Base salary reference$275,000 since 2018 per agreement, subject to committee adjustment (actual paid may vary) .
Annual bonusDiscretionary, based on corporate/strategic goals set by compensation committee .
Non-compete/non-solicit1-year post-employment non-compete and standard confidentiality/work-for-hire provisions .
Severance (without cause)Greater of nine months of then-current base salary or the months remaining in the term .
Change-in-control (employment)If not offered continued employment at close or terminated without cause within five years post-CIC: accrued pay/benefits, prorated current-year bonus, plus 2x then-current base salary .
Equity on CIC (plans)2015 Plan: immediate vesting of all options/termination of restrictions (single-trigger) . 2023 Plan: board/committee may accelerate vesting on CIC; 40% beneficial ownership threshold included in CIC definition .
ClawbackAwards subject to company clawback policy; no recovery required for 2023 restatement (no incentive comp subject to recovery) .

Board Governance

  • Roles: DePasquale serves as combined Chairman and CEO; the board has determined this structure is in the best interests of stockholders and there is no Lead Independent Director .
  • Independence: Majority independent directors (Michel, Alia, Williams) per Nasdaq standards .
  • Committees: Audit (Chair: Williams; members: Michel, Alia; 4 meetings in 2024); Compensation (Chair: Williams; member: Michel; 1 meeting in 2024); Nominating & Corporate Governance (Chair: Alia; member: Williams; 1 meeting in 2024) .
  • Attendance: Board held seven meetings in 2024; each director attended at least 75% of board and committee meetings .
  • Director compensation: DePasquale and Kelvin Wong receive no additional compensation for board service. Non-employee directors were paid $3,000 per regular board meeting and $1,000 per committee meeting in 2024 (mix of stock and cash), with example 2024 director totals shown (Michel $13,002; Alia $12,002; Williams $13,002) .

Director Voting and Say‑on‑Pay

Item20242025
Michael DePasquale – director election votes (For/Withheld/Broker non‑votes)368,965 / 98,549 / 667,346 1,000,092 / 300,305 / 2,713,111
Say‑on‑Pay (For/Against/Abstentions/Broker non‑votes)302,123 / 101,061 / 64,330 / 667,346 975,360 / 317,871 / 7,166 / 2,713,111

Performance & Track Record

Measure20232024
Revenue ($)7,754,905 6,929,571
Net Loss ($)(8,521,837) (4,300,692)
Gross Profit ($)1,431,319 5,640,186
  • Mix shift and margin: 2024 gross profit improved due to reduced hardware reserves, growth in higher‑margin license sales, and lower service/hardware revenue mix; exit of Swivel Secure distribution reduced third‑party license fees and support costs .
  • Operating discipline: SG&A decreased 9% in 2024; R&D increased 5% to support new products .
  • Restatement and controls: 2023 interim periods were restated for revenue/accounts receivable and inventory reserve errors; management cited remediation actions in 2024 (EMEA invoice/revenue oversight, added inventory analysis) .

Related Party Transactions

  • October 31, 2023 public offering participation: DePasquale purchased 9,167 common shares and a warrant to purchase 9,167 shares for $28,875 total .
  • Standstill with principal stockholder (Kelvin Wong) limits accumulation/solicitation/board representation; Kelvin is Co‑Chairman and an executive officer .

Compensation Committee and Policies

  • Compensation committee comprised of independent directors; oversees philosophy, pay levels, and equity plan administration, operating under a written charter .
  • Hedging/pledging policy prohibits hedging and margin; no pledging while in possession of MNPI .
  • Clawback policy on file (10‑K exhibit); plan documents include forfeiture/recoupment for “Cause”/“Adverse Action” .
  • Equity plan governance protections include no option re‑pricing without stockholder approval; no tax gross‑ups; non‑employee director compensation limits .

Equity Ownership & Vesting Overhang (Detail)

Beneficial ownership breakdownCount
Total beneficial ownership (CEO)62,918
Options exercisable232
Warrants9,167
Restricted stock (total)28,120; 17,297 unvested
Reference market price (12/31/24)$1.71 per share (used for RSU fair value table)
Company outstanding shares (6/20/25)6,848,775

Employment Contracts, Severance, and Change‑of‑Control Economics

  • Term: Auto‑renewing one‑year terms unless terminated or modified .
  • Severance (without cause): Salary continuation for greater of nine months or remaining term months .
  • Change‑in‑control: If no continued employment offer or termination without cause within five years post‑CIC, CEO receives accrued pay/benefits, prorated current‑year bonus, plus 2× then‑current base salary; equity treatment per plans (2015: immediate acceleration; 2023: committee discretion to accelerate) .

Board Service History and Dual‑Role Implications

  • Board service: Director since 2003; Chairman since 2014; elected by stockholders most recently on August 8, 2025 with 1,000,092 For and 300,305 Withheld votes .
  • Committee roles: CEO/Chairman does not serve on Audit, Compensation, or Nominating committees; committees are composed of independent directors (Audit: Williams (Chair), Michel, Alia; Compensation: Williams (Chair), Michel; Nominating: Alia (Chair), Williams) .
  • Independence/leadership: Combined Chair/CEO structure with no Lead Independent Director; board asserts benefits from CEO’s company/industry knowledge; governance trade‑off for independence highlighted .
  • Attendance: Board met seven times in 2024; all directors met 75% attendance threshold .

Investment Implications

  • Pay-for-performance: No annual cash bonuses paid in 2022–2024; “Compensation Actually Paid” moved modestly while TSR proxy declined over 2022–2024, and net losses narrowed—indicating limited realized upside tied to stock performance to date .
  • Retention and selling pressure: 24,000 CEO RSUs begin vesting July 31, 2025, with a separate 1,945‑share tranche vesting from August 29, 2025; combined with company-wide equity overhang (current 3.6%, potential 15.0% under the amended plan), this creates periodic vesting supply that may weigh on trading liquidity around vest dates .
  • CIC protection profile: 2× base salary cash severance plus prorated bonus (employment agreement) is moderate; equity acceleration is single‑trigger under the 2015 plan but discretionary (board/committee) under the 2023 plan—mitigating windfalls in certain scenarios .
  • Governance risk: Combined Chair/CEO with no Lead Independent Director and a prior 2023 restatement (with remediation steps) are governance watch‑items for control and oversight; however, independent committee structures and clawback/hedging policies are mitigating factors .
  • Alignment: CEO’s equity includes largely out‑of‑the‑money legacy options (strikes $169.92–$282.24 vs $1.71 at 12/31/24) and time‑vesting RSUs; near‑term alignment rests more on service‑based RSU vesting than option upside, which may dilute pay-for-performance sensitivity absent performance‑conditioned equity .

Overall: The CEO’s package is predominantly salary plus time‑vested equity with no cash bonus paid in recent years; upcoming RSU vesting is the key incentive/retention lever and potential trading overhang, while CIC terms are moderate and governance structure warrants monitoring .